Capital Rotating Into Healthcare Sector as Defensive Play for 2027, with XLV Leading Large ETFs

Investors are shifting capital into the healthcare sector as a defensive alternative to volatile technology and artificial intelligence trades heading into 2027, according to analysis published Monday. Healthcare ETFs including XLV, VHT, and FHLC are drawing the bulk of inflows, with XLV, the Health Care Select Sector SPDR Fund, emerging as the largest vehicle in the space at $49.19 billion in assets under management and a year-to-date return of roughly 20.72%.

The rotation is underpinned by structural demand: healthcare spending is projected to grow at 5.4% annually through 2034, a pace that outstrips broader GDP growth and supports the case for durable, long-term sector exposure. VHT, with $20.80 billion in AUM and a 19.77% year-to-date gain, offers broader diversification across 411 stocks compared to XLV's more concentrated 63 S&P 500 holdings.

Within the sector, individual stocks including GE HealthCare Technologies and a range of other healthcare names were active in pre-market trading Monday. BioNTech and Moderna are also drawing attention as both companies work to expand pipelines beyond COVID-19 vaccines into oncology and other disease areas, with analysts flagging one as holding a potential edge into 2027.